Executives at Amgen (NASDAQ:AMGN) outlined several upcoming clinical milestones and recent data updates across its ...

Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be increasing its dividend from last year's comparable payment ...

But Amgen’s true success stems from putting people first. By creating an environment where innovation, inclusion and ...

Amgen Inc. (NASDAQ:AMGN) is one of the best medical research stocks to buy according to hedge funds. Amgen Inc. (NASDAQ:AMGN) ...

Amgen's Uplizna receives European approval to treat generalized myasthenia gravis: Thousand Oaks, California Saturday, February 14, 2026, 11:00 Hrs [IST] Amgen announced the Europ ...

Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...

The decision by the EC was supported by data from the Myasthenia Gravis Inebilizumab Trial.

Amgen’s fourth-quarter results reflected broad-based sales growth across its diverse portfolio, with management crediting strong volume gains in key products such as Repatha, Evenity, and Tezspire.

US biotech giant Amgen today announced the European Commission (EC) has approved Uplizna (inebilizumab) as an add-on ...

Piper Sandler Virtual Novel Targets in Immunology Symposium February 12, 2026 5:00 PM ESTCompany ParticipantsPaul Burton - Senior VP ...

PEBBLE BEACH, Calif. – Rory McIlroy played 68 great holes of golf at the AT&T Pebble Beach Pro-Am this week. Well, there’s a reason McIlroy’s final round finished as the leaders were making the turn ...